|
1
|
Chen Y, Xie H, Gao Q, Zhan H, Xiao H, Zou
Y, Zhang F, Liu Y and Li J: Colon cancer associated transcripts in
human cancers. Biomed Pharmacother. 94:531–540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tahir AA, Sani NF, Murad NA, Makpol S,
Ngah WZ and Yusof YA: Combined ginger extract & Gelam honey
modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29
cells. Nutr J. 14:312015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye J, Talaiti A, Ma Y, Zhang Q, Ma L and
Zheng H: Allergies and risk of colorectal cancer: A systematic
review and meta-analysis of observational studies. Oncotarget.
8:14646–14654. 2017.PubMed/NCBI
|
|
4
|
Setia S, Nehru B and Sanyal SN:
Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative
colitis-associated colon cancer. Biomed Pharmacother. 68:1023–1029.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Yuan J, Zhang X, Yan F, Huang M,
Wang T, Zheng X and Zhang M: Angiomotin promotes the malignant
potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT
signaling pathway. Oncol Rep. 36:3619–3626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Urosevic J, Nebreda AR and Gomis RR: MAPK
signaling control of colon cancer metastasis. Cell Cycle.
13:2641–2642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dziegielewska B, Brautigan DL, Larner JM
and Dziegielewski J: T-type Ca2+ channel inhibition
induces p53-dependent cell growth arrest and apoptosis through
activation of p38-MAPK in colon cancer cells. Mol Cancer Res.
12:348–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zuo L, Yang X, Lu M, Hu R, Zhu H, Zhang S,
Zhou Q, Chen F, Gui S and Wang Y: All-trans retinoic acid inhibits
human colorectal cancer cells RKO migration via downregulating
myosin light chain kinase expression through MAPK signaling
pathway. Nutr Cancer. 68:1225–1233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gröschl B, Bettstetter M, Giedl C,
Woenckhaus M, Edmonston T, Hofstädter F and Dietmaier W: Expression
of the MAP kinase phosphatase DUSP4 is associated with
microsatellite instability in colorectal cancer (CRC) and causes
increased cell proliferation. Int J Cancer. 132:1537–1546. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Randhawa H, Kibble K, Zeng H, Moyer MP and
Reindl KM: Activation of ERK signaling and induction of colon
cancer cell death by piperlongumine. Toxicol In Vitro.
27:1626–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao JD, Wu P, Huang JX, Wu J and Yang G:
Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth
of large intestinal carcinoma. World J Gastroenterol.
20:12542–12550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Y, Fan D, Zheng ZP, Li ET, Chen F,
Cheng KW and Wang M: 8-C-(E-phenylethenyl)quercetin from onion/beef
soup induces autophagic cell death in colon cancer cells through
ERK activation. Mol Nutr Food Res. 61:16004372017. View Article : Google Scholar
|
|
13
|
Radziwon-Balicka A, Santos-Martinez MJ,
Corbalan JJ, O'Sullivan S, Treumann A, Gilmer JF, Radomski MW and
Medina C: Mechanisms of platelet-stimulated colon cancer invasion:
Role of clusterin and thrombospondin 1 in regulation of the
P38MAPK-MMP-9 pathway. Carcinogenesis. 35:324–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee M, Young Kim S, Kim J, Kim HS, Kim SM
and Kim EJ: Mitogen-activated protein kinase phosphatase-1
inhibition and sustained extracellular signal-regulated kinase 1/2
activation in camptothecin-induced human colon cancer cell death.
Cancer Biol Ther. 14:1007–1015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Slattery ML, Lundgreen A and Wolff RK:
Dietary influence on MAPK-signaling pathways and risk of colon and
rectal cancer. Nutr Cancer. 65:729–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enayat S, Ceyhan MŞ, Başaran AA, Gürsel M
and Banerjee S: Anticarcinogenic effects of the ethanolic extract
of Salix aegyptiaca in colon cancer cells: Involvement of
Akt/PKB and MAPK pathways. Nutr Cancer. 65:1045–1058. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen B, Zeng X, He Y, Wang X, Liang Z, Liu
J, Zhang P, Zhu H, Xu N and Liang S: STC2 promotes the
epithelial-mesenchymal transition of colorectal cancer cells
through AKT-ERK signaling pathways. Oncotarget. 7:71400–71416.
2016.PubMed/NCBI
|
|
18
|
Bodur C, Kutuk O, Karsli-Uzunbas G,
Isimjan TT, Harrison P and Basaga H: Pramanicin analog induces
apoptosis in human colon cancer cells: Critical roles for Bcl-2,
Bim, and p38 MAPK signaling. PLoS One. 8:e563692013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang P, Kawakami H, Liu W, Zeng X,
Strebhardt K, Tao K, Huang S and Sinicrope FA: Targeting CDK1 and
MEK/ERK overcomes apoptotic resistance in BRAF-mutant human
colorectal cancer. Mol Cancer Res. 16:378–389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Najar AG, Pashaei-Asl R, Omidi Y, Farajnia
S and Nourazarian AR: EGFR antisense oligonucleotides encapsulated
with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a
human colon cancer cell line. Asian Pac J Cancer Prev. 14:495–498.
2013. View Article : Google Scholar : PubMed/NCBI
|
